<p>Surrozen, Inc.（纳斯达克代码：SRZN - 获取免费报告）董事 Tim Kutzkey 于 11 月 13 日星期四收购了 315,457 股该公司的股票。该股票的平均收购价格为每股 12.65 美元，总价值为 3,990,531.05 美元。交易完成后，该董事在公司持有 962,718 股，估值约为 12,178,382.70 美元。此次交易使其持股增加了 48.74%。该交易已在与证券交易委员会的法律文件中披露，您可以通过此链接访问。</p>
<h2>Surrozen 股票表现</h2>
<p>在周二的交易中，纳斯达克 SRZN 的股价下跌 0.58 美元，达到 15.54 美元。该公司的交易量为 100,264 股，而其平均交易量为 92,641 股。Surrozen, Inc.的 52 周最低价为 5.90 美元，52 周最高价为 18.17 美元。该公司的 50 日移动平均价格为 13.51 美元，200 日移动平均价格为 11.11 美元。该股票的市值为 1.3318 亿美元，市盈率为-0.70，贝塔值为 0.62。</p>
<p>Surrozen（纳斯达克：SRZN - 获取免费报告）最近于 11 月 7 日星期五发布了其财报。该公司报告本季度每股收益（EPS）为-3.61 美元，低于市场共识预期的-1.17 美元，差距为-2.44 美元。Surrozen 的净利润率为-2,909.10%，股本回报率为-4,055.04%。该公司本季度的收入为 98 万美元。股票分析师预计 Surrozen, Inc.在本年度的每股收益将为-8.49 美元。</p>
<h2>对 Surrozen 的对冲基金看法</h2>
<p>一些对冲基金最近增加或减少了在 SRZN 的持股。Adage Capital Partners GP L.L.C.在第一季度将其在 Surrozen 的持股增加了 37.1%。Adage Capital Partners GP L.L.C.现在拥有 88,653 股该公司的股票，价值 1,034,000 美元，此前在上个季度又收购了 24,000 股。Driehaus Capital Management LLC 在第一季度收购了 Surrozen 的新股份，价值约为 2,390,000 美元。Stonepine Capital Management LLC 在第一季度将其在 Surrozen 的持股增加了 108.3%。Stonepine Capital Management LLC 现在拥有 285,782 股该公司的股票，价值 3,332,000 美元，此前在上个季度又购买了 148,582 股。RA Capital Management L.P.在第一季度将其在 Surrozen 的持股增加了 140.3%。RA Capital Management L.P.现在拥有 679,130 股该公司的股票，价值 7,919,000 美元，此前在上个季度又购买了 396,550 股。最后，Vivo Capital LLC 在第一季度收购了 Surrozen 的新股份，价值约为 3,032,000 美元。机构投资者持有该公司 66.57% 的股票。</p>
<h2>分析师设定新目标价</h2>
<p>几家券商最近对 SRZN 发表了评论。Weiss Ratings 在 10 月 8 日星期三的报告中重申了对 Surrozen 股票的 “卖出（d-）” 评级。Lifesci Capital 在 11 月 13 日星期四的研究报告中将 Surrozen 的评级上调至 “强力买入”。最后，Wall Street Zen 在周五的报告中将 Surrozen 的评级上调至 “卖出”。一位股票研究分析师对该股票给予了强力买入评级，两位给予了买入评级，一位对该公司的股票给予了卖出评级。根据 MarketBeat 的数据，该股票的平均评级为 “适度买入”，共识目标价为 38.50 美元。</p>
<p><strong>获取我们关于 SRZN 的最新报告</strong></p>
<h2>关于 Surrozen</h2>
<p>（获取免费报告）</p>
<p>Surrozen, Inc.是一家临床阶段的生物技术公司，发现并开发药物候选物，以选择性调节 Wnt 通路以促进组织修复。该公司正在开发针对多种疾病领域的抗体基础治疗，包括肠道、肝脏、视网膜、角膜、肺、肾脏、耳蜗、皮肤、胰腺和中枢神经系统的疾病。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票而非 Surrozen</li>
<li>哪些华尔街分析师最准确？</li>
<li>华尔街的沉睡巨人：亚马逊即将觉醒？</li>
<li>为什么股票行业对成功投资至关重要？</li>
<li>云端的绝杀：ServiceNow 的购物狂欢</li>
<li>如何开始投资于便士股票</li>
<li>在 MSCI 退市风波中，MSTR 的逆向投资案例</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Surrozen 吗？</h2>
<p>在考虑 Surrozen 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐现在购买，以便在更广泛的市场注意到之前……而 Surrozen 并不在名单上。</p>
<p>虽然 Surrozen 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

SRZN

<p>Surrozen, Inc. 的董事 Tim Kutzkey 以每股 12.65 美元的价格购买了 315,457 股公司股票，总计 3,990,531.05 美元。这次收购使他的持股增加了 48.74%，现在拥有 962,718 股，价值 12,178,382.70 美元。该交易已在 SEC 文件中披露。Surrozen 的股票表现显示近期下滑，交易量为 100,264 股，市值为 1.3318 亿美元。分析师对该股票的评级不一，普遍目标价为 38.50 美元</p>

<p>Surrozen, Inc. (NASDAQ:SRZN - Get Free Report) Director Tim Kutzkey acquired 315,457 shares of the business's stock in a transaction on Thursday, November 13th. The stock was acquired at an average price of $12.65 per share, with a total value of $3,990,531.05. Following the transaction, the director owned 962,718 shares in the company, valued at approximately $12,178,382.70. The trade was a 48.74% increase in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this link.</p>
<div class="lb-trans"><p>Surrozen, Inc.（纳斯达克代码：SRZN - 获取免费报告）董事 Tim Kutzkey 于 11 月 13 日星期四收购了 315,457 股该公司的股票。该股票的平均收购价格为每股 12.65 美元，总价值为 3,990,531.05 美元。交易完成后，该董事在公司持有 962,718 股，估值约为 12,178,382.70 美元。此次交易使其持股增加了 48.74%。该交易已在与证券交易委员会的法律文件中披露，您可以通过此链接访问。</p>
</div><h2>Surrozen Stock Performance</h2>
<div class="lb-trans"><h2>Surrozen 股票表现</h2>
</div><p>Shares of NASDAQ SRZN traded down $0.58 during trading on Tuesday, reaching $15.54. The company had a trading volume of 100,264 shares, compared to its average volume of 92,641. Surrozen, Inc. has a 52 week low of $5.90 and a 52 week high of $18.17. The business's 50 day moving average price is $13.51 and its 200-day moving average price is $11.11. The stock has a market cap of $133.18 million, a PE ratio of -0.70 and a beta of 0.62.</p>
<div class="lb-trans"><p>在周二的交易中，纳斯达克 SRZN 的股价下跌 0.58 美元，达到 15.54 美元。该公司的交易量为 100,264 股，而其平均交易量为 92,641 股。Surrozen, Inc.的 52 周最低价为 5.90 美元，52 周最高价为 18.17 美元。该公司的 50 日移动平均价格为 13.51 美元，200 日移动平均价格为 11.11 美元。该股票的市值为 1.3318 亿美元，市盈率为-0.70，贝塔值为 0.62。</p>
</div><p>Surrozen (NASDAQ:SRZN - Get Free Report) last issued its earnings results on Friday, November 7th. The company reported ($3.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.17) by ($2.44). Surrozen had a negative net margin of 2,909.10% and a negative return on equity of 4,055.04%. The business had revenue of $0.98 million during the quarter. Equities analysts anticipate that Surrozen, Inc. will post -8.49 earnings per share for the current year.</p>
<div class="lb-trans"><p>Surrozen（纳斯达克：SRZN - 获取免费报告）最近于 11 月 7 日星期五发布了其财报。该公司报告本季度每股收益（EPS）为-3.61 美元，低于市场共识预期的-1.17 美元，差距为-2.44 美元。Surrozen 的净利润率为-2,909.10%，股本回报率为-4,055.04%。该公司本季度的收入为 98 万美元。股票分析师预计 Surrozen, Inc.在本年度的每股收益将为-8.49 美元。</p>
</div><h2>Hedge Funds Weigh In On Surrozen</h2>
<div class="lb-trans"><h2>对 Surrozen 的对冲基金看法</h2>
</div><p>A number of hedge funds have recently added to or reduced their stakes in SRZN. Adage Capital Partners GP L.L.C. grew its position in Surrozen by 37.1% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 88,653 shares of the company's stock worth $1,034,000 after acquiring an additional 24,000 shares during the last quarter. Driehaus Capital Management LLC acquired a new stake in shares of Surrozen during the first quarter valued at about $2,390,000. Stonepine Capital Management LLC boosted its stake in shares of Surrozen by 108.3% during the first quarter. Stonepine Capital Management LLC now owns 285,782 shares of the company's stock valued at $3,332,000 after purchasing an additional 148,582 shares in the last quarter. RA Capital Management L.P. grew its holdings in shares of Surrozen by 140.3% during the first quarter. RA Capital Management L.P. now owns 679,130 shares of the company's stock worth $7,919,000 after purchasing an additional 396,550 shares during the last quarter. Finally, Vivo Capital LLC acquired a new position in shares of Surrozen in the first quarter valued at approximately $3,032,000. Institutional investors own 66.57% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金最近增加或减少了在 SRZN 的持股。Adage Capital Partners GP L.L.C.在第一季度将其在 Surrozen 的持股增加了 37.1%。Adage Capital Partners GP L.L.C.现在拥有 88,653 股该公司的股票，价值 1,034,000 美元，此前在上个季度又收购了 24,000 股。Driehaus Capital Management LLC 在第一季度收购了 Surrozen 的新股份，价值约为 2,390,000 美元。Stonepine Capital Management LLC 在第一季度将其在 Surrozen 的持股增加了 108.3%。Stonepine Capital Management LLC 现在拥有 285,782 股该公司的股票，价值 3,332,000 美元，此前在上个季度又购买了 148,582 股。RA Capital Management L.P.在第一季度将其在 Surrozen 的持股增加了 140.3%。RA Capital Management L.P.现在拥有 679,130 股该公司的股票，价值 7,919,000 美元，此前在上个季度又购买了 396,550 股。最后，Vivo Capital LLC 在第一季度收购了 Surrozen 的新股份，价值约为 3,032,000 美元。机构投资者持有该公司 66.57% 的股票。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several brokerages recently commented on SRZN. Weiss Ratings reiterated a &#34;sell (d-)&#34; rating on shares of Surrozen in a report on Wednesday, October 8th. Lifesci Capital upgraded Surrozen to a &#34;strong-buy&#34; rating in a research note on Thursday, November 13th. Finally, Wall Street Zen raised Surrozen to a &#34;sell&#34; rating in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $38.50.</p>
<div class="lb-trans"><p>几家券商最近对 SRZN 发表了评论。Weiss Ratings 在 10 月 8 日星期三的报告中重申了对 Surrozen 股票的 “卖出（d-）” 评级。Lifesci Capital 在 11 月 13 日星期四的研究报告中将 Surrozen 的评级上调至 “强力买入”。最后，Wall Street Zen 在周五的报告中将 Surrozen 的评级上调至 “卖出”。一位股票研究分析师对该股票给予了强力买入评级，两位给予了买入评级，一位对该公司的股票给予了卖出评级。根据 MarketBeat 的数据，该股票的平均评级为 “适度买入”，共识目标价为 38.50 美元。</p>
</div><p><strong>Get Our Latest Report on SRZN</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 SRZN 的最新报告</strong></p>
</div><h2>About Surrozen</h2>
<div class="lb-trans"><h2>关于 Surrozen</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.</p>
<div class="lb-trans"><p>Surrozen, Inc.是一家临床阶段的生物技术公司，发现并开发药物候选物，以选择性调节 Wnt 通路以促进组织修复。该公司正在开发针对多种疾病领域的抗体基础治疗，包括肠道、肝脏、视网膜、角膜、肺、肾脏、耳蜗、皮肤、胰腺和中枢神经系统的疾病。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Surrozen</li>
<li>Which Wall Street Analysts are the Most Accurate?</li>
<li>Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?</li>
<li>Why Are Stock Sectors Important to Successful Investing?</li>
<li>Checkmate in the Cloud: ServiceNow's Shopping Spree</li>
<li>How to start investing in penny stocks</li>
<li>The Contrarian Case for MSTR Amid MSCI Delisting Debacle</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票而非 Surrozen</li>
<li>哪些华尔街分析师最准确？</li>
<li>华尔街的沉睡巨人：亚马逊即将觉醒？</li>
<li>为什么股票行业对成功投资至关重要？</li>
<li>云端的绝杀：ServiceNow 的购物狂欢</li>
<li>如何开始投资于便士股票</li>
<li>在 MSCI 退市风波中，MSTR 的逆向投资案例</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Surrozen Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Surrozen 吗？</h2>
</div><p>Before you consider Surrozen, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Surrozen 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surrozen wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐现在购买，以便在更广泛的市场注意到之前……而 Surrozen 并不在名单上。</p>
</div><p>While Surrozen currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Surrozen 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Tim Kutzkey 购买了 315,457 股 Surrozen（纳斯达克代码：SRZN）的股票